NCT01559883

Brief Summary

The study aims to document the flow of German patients with cancer and acute deep vein thrombosis from first visit to diagnosis and treatment, the applied diagnostic procedures, and therapy modalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2012

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 21, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

August 15, 2014

Status Verified

November 1, 2013

Enrollment Period

1.8 years

First QC Date

March 1, 2012

Last Update Submit

August 14, 2014

Conditions

CancerDeep Vein ThrombosisPulmonary Embolism

Keywords

cancerthrombosispulmonary embolismanticoagulationlow molecular weight heparin

Outcome Measures

Primary Outcomes (1)

  • treatment time on low molecular weight heparin

    1 year

Secondary Outcomes (2)

  • patient pathways

    1 year

  • risk factors for DVT

    1 year

Study Arms (1)

all eligible patients

there is only 1 Cohort in which all patients participating in this NIS are included

Other: no intervention is being made

Interventions

no intervention is being madeOTHER

This is a Non-Interventional Study (NIS)

all eligible patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cancer patient with acute deep vein throbosis/ pulmonary embolism in ambulatory oncology care/practice

You may qualify if:

  • patient with cancer and acute deep vein thrombosis and/or pulmonary embolism

You may not qualify if:

  • life expectancy less that 6 months
  • age less that 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Dr. Axel Matzdorff

Saarbrücken, Saarland, 66111, Germany

Location

MeSH Terms

Conditions

NeoplasmsVenous ThrombosisPulmonary EmbolismThrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular DiseasesLung DiseasesRespiratory Tract DiseasesEmbolism

Study Officials

  • Axel Matzdorff, Prof.Dr.

    Caritasklinikum Saarbrücken, St. Theresia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2012

First Posted

March 21, 2012

Study Start

February 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

August 15, 2014

Record last verified: 2013-11

Locations

DE(1)